You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Sunday, October 27, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - WEDNESDAY, JUNE 30TH, 2010
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 9895.62 25.32 (0.26%) | NASDAQ 2150.46 15.28 (0.72%) | S&P 500 1045.86 4.62 (0.44%)
|
Time of Screening :
6/30/2010 12:03:24 PM Report Released :
6/30/2010 12:26:31 PM
Price is:
Above 52W High and Less Than 52W High
but within 5% of the 52 Week High
Volume Is:
At least 57.5% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
|
NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
ABC
- NYSE - Medical-Whlsle Drg/Suppl
Amerisourcebergen Corp
|
$32.20 |
+0.48
1.51%
|
$32.36
|
$33.27
|
-3.22% |
2,943,682
66.50%
|
4,426,300
|
Most Recent Note for ABC - 6/30/2010 12:04:46 PM
Consolidating above support above its 50 DMA line. It has traded up in 13 out of 15 months. Noted in recent mid-day reports - "Earnings showed better increases in the 2 latest quarters but prior comparisons have been below guidelines and sales revenues growth has been below guidelines. It shown steady annual earnings (A criteria) growth in recent years."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EW
- NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Edwards Lifesciences Cp
|
$55.87 |
+2.04
3.79%
|
$55.93
|
$56.00
|
-0.23% |
595,410
59.48%
|
1,001,100
|
Most Recent Note for EW - 6/30/2010 12:13:52 PM
Considerable gain today for a new 52-week high. Noted in prior mid-day reports that it - "endured numerous distribution days since March yet it held up well, and on 5/28/10 its share price was impacted by a 2:1 split . The Medical - Products firm has a slow but steady annual earnings history. Quarterly sales revenues and earnings increases have been below guidelines. With respect to the N criteria, explosive sales revenues increases would be a true indication of great or growing demand for any company's products."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MNRO
- NASDAQ - RETAIL - Auto Parts and Sercices
Monro Muffler Brake
|
$40.46 |
+1.70
4.39%
|
$40.64
|
$40.64
|
-0.44% |
237,404
95.04%
|
249,800
|
Most Recent Note for MNRO - 6/30/2010 12:16:16 PM
Considerable gain today for a new 52-week high and new all-time high, leaving it clear of any resistance due to overhead supply. Earnings and sales revenues increases have been much stronger in recent quarterly comparisons (C criteria) while its annual earnings (A criteria) growth rate has been steady but not especially strong. It and similar players in the auto-repair arena have shown recent strength while consumers are fixing their old cars and holding off on new car purchases. However, in 6 of its 8 most recent quarterly earnings comparisons there are blue triangles beside the earnings figure on the chart service used by our experts - which indicates pre-tax, non-recurring items were included (where possible, such items are normally removed to provide data better suited for comparison).
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$81.95 |
+1.00
1.24%
|
$81.96
|
$85.86
|
-4.55% |
316,586
91.21%
|
347,100
|
Most Recent Note for NVO - 6/30/2010 12:21:16 PM
This Denmark-based Medical - Ethical Drug firm has been quietly consolidating above its 50 DMA line, pulling back since gapping up and being noted in the 6/18 and 6/21 mid-day reports - "It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. Quarterly comparisons show sales and earnings increases mostly below guidelines of the fact-based investment system."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
